{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:57:42Z","timestamp":1793278662776,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T00:00:00Z","timestamp":1432684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T00:00:00Z","timestamp":1432684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Secondary osteoporosis is common in systemic lupus erythematosus and leads to a reduction in quality of life due to fragility fractures, even in patients with improvement of the primary disorder. Systemic transplantation of mesenchymal stem cells could ameliorate bone loss and autoimmune disorders in a MRL\/<jats:italic>lpr<\/jats:italic> mouse systemic lupus erythematosus model, but the detailed therapeutic mechanism of bone regeneration is not fully understood. In this study, we transplanted human bone marrow mesenchymal stem cells (BMMSCs) and stem cells from exfoliated deciduous teeth (SHED) into MRL\/<jats:italic>lpr<\/jats:italic> mice and explored their therapeutic mechanisms in secondary osteoporotic disorders of the systemic lupus erythematosus model mice.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>The effects of systemic human mesenchymal stem cell transplantation on bone loss of MRL<jats:italic>\/lpr<\/jats:italic> mice were analyzed in vivo and ex vivo. After systemic human mesenchymal stem cell transplantation, recipient BMMSC functions of MRL<jats:italic>\/lpr<\/jats:italic> mice were assessed for aspects of stemness, osteogenesis and osteoclastogenesis, and a series of co-culture experiments under osteogenic or osteoclastogenic inductions were performed to examine the efficacy of interleukin (IL)-17-impaired recipient BMMSCs in the bone marrow of MRL<jats:italic>\/lpr<\/jats:italic> mice.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Systemic transplantation of human BMMSCs and SHED recovered the reduction in bone density and structure in MRL\/<jats:italic>lpr<\/jats:italic> mice. To explore the mechanism, we found that impaired recipient BMMSCs mediated the negative bone metabolic turnover by enhanced osteoclastogenesis and suppressed osteoblastogenesis in secondary osteoporosis of MRL\/<jats:italic>lpr<\/jats:italic> mice. Moreover, IL-17-dependent hyperimmune conditions in the recipient bone marrow of MRL\/<jats:italic>lpr<\/jats:italic> mice damaged recipient BMMSCs to suppress osteoblast capacity and accelerate osteoclast induction. To overcome the abnormal bone metabolism, systemic transplantation of human BMMSCs and SHED into MRL\/<jats:italic>lpr<\/jats:italic> mice improved the functionally impaired recipient BMMSCs through IL-17 suppression in the recipient bone marrow and then maintained a regular positive bone metabolism via the balance of osteoblasts and osteoclasts.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>These findings indicate that IL-17 and recipient BMMSCs might be a therapeutic target for secondary osteoporosis in systemic lupus erythematosus.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/s13287-015-0091-4","type":"journal-article","created":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T13:52:53Z","timestamp":1432648373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Transplantation of mesenchymal stem cells ameliorates secondary osteoporosis through interleukin-17-impaired functions of recipient bone marrow mesenchymal stem cells in MRL\/lpr mice"],"prefix":"10.1186","volume":"6","author":[{"given":"Lan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reona","family":"Aijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruyoshi","family":"Yamaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Tomoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangtai","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Nonaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songtao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Yamaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,27]]},"reference":[{"key":"91_CR1","first-page":"307","volume-title":"Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism","author":"C Cooper","year":"2003","unstructured":"Cooper C. Epidemiology of osteonecrosis. In: Favus M, editor. Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism. Washington DC: American Society for Bone and Mineral Research; 2003. p. 307\u201313."},{"key":"91_CR2","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nrrheum.2012.93","volume":"8","author":"K Walker-Bone","year":"2012","unstructured":"Walker-Bone K. Recognizing and treating secondary osteoporosis. Nat Rev Rheumatol. 2012;8:480\u201392.","journal-title":"Nat Rev Rheumatol."},{"key":"91_CR3","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/ncprheum0298","volume":"2","author":"NE Lane","year":"2006","unstructured":"Lane NE. Therapy Insight: osteoporosis and osteonecrosis in systemic lupus erythematosus. Nat Clin Pract Rheumatol. 2006;2:562\u20139.","journal-title":"Nat Clin Pract Rheumatol."},{"key":"91_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/acr.20568","volume":"64","author":"IE Bultink","year":"2012","unstructured":"Bultink IE. Osteoporosis and fractures in systemic lupus erythematosus. Arthritis Care Res. 2012;64:2\u20138.","journal-title":"Arthritis Care Res."},{"key":"91_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143\u20137.","journal-title":"Science."},{"key":"91_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.stem.2008.01.007","volume":"2","author":"A Keating","year":"2008","unstructured":"Keating A. How do mesenchymal stromal cells suppress T cells? Cell Stem Cell. 2008;2:106\u20138.","journal-title":"Cell Stem Cell."},{"key":"91_CR7","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","volume":"110","author":"AJ Nauta","year":"2007","unstructured":"Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stem cells. Blood. 2007;110:3499\u2013506.","journal-title":"Blood."},{"key":"91_CR8","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","volume":"363","author":"K Le Blanc","year":"2004","unstructured":"Le Blanc K, Rasmusson I, Sundberg B, G\u00f6therstr\u00f6m C, Hassan M, Uzunel M, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439\u201341.","journal-title":"Lancet."},{"key":"91_CR9","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1053\/j.gastro.2008.11.041","volume":"136","author":"MA Gonz\u00e1lez","year":"2009","unstructured":"Gonz\u00e1lez MA, Gonzalez-Rey E, Rico L, B\u00fcscher D, Delgado M. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology. 2009;136:978\u201389.","journal-title":"Gastroenterology."},{"key":"91_CR10","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/stem.68","volume":"27","author":"L Sun","year":"2009","unstructured":"Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S, et al. Mesenchymal stem cell transplantation reverses multi-organ dysfunction in systemic lupus erythematosus mice and humans. Stem Cells. 2009;27:1421\u201332.","journal-title":"Stem Cells."},{"key":"91_CR11","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1002\/art.27548","volume":"62","author":"L Sun","year":"2010","unstructured":"Sun L, Wang D, Liang J, Zhang H, Feng X, Wang H, et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum. 2010;62:2467\u201375.","journal-title":"Arthritis Rheum."},{"key":"91_CR12","doi-asserted-by":"crossref","unstructured":"Wang D, Zhang H, Liang J, Li X, Feng X, Wang H, et al. Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years experience. Cell Transplant. 2013;22:2267\u201377.","DOI":"10.3727\/096368911X582769c"},{"key":"91_CR13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0065-2776(08)60342-9","volume":"37","author":"AN Theofilopoulos","year":"1985","unstructured":"Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol. 1985;37:269\u2013390.","journal-title":"Adv Immunol."},{"key":"91_CR14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/cmi.2008.52","volume":"5","author":"K Zhou","year":"2008","unstructured":"Zhou K, Zhang H, Jin O, Feng X, Yao G, Hou Y, et al. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL\/lpr mice. Cell Mol Immunol. 2008;5:417\u201324.","journal-title":"Cell Mol Immunol."},{"key":"91_CR15","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1177\/0961203310373782","volume":"19","author":"Z Gu","year":"2010","unstructured":"Gu Z, Akiyama K, Ma X, Zhang H, Feng X, Yao G, et al. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL\/lpr mice. Lupus. 2010;19:1502\u201314.","journal-title":"Lupus."},{"key":"91_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/scrt5","volume":"1","author":"T Yamaza","year":"2010","unstructured":"Yamaza T, Akiyama K, Chen C, Liu Y, Shi Y, Gronthos S, et al. Immunomodulatory properties of stem cells from human exfoliated deciduous teeth. Stem Cell Res Ther. 2010;1:5.","journal-title":"Stem Cell Res Ther."},{"key":"91_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051777","volume":"7","author":"L Ma","year":"2012","unstructured":"Ma L, Makino Y, Yamaza H, Akiyama K, Hoshino Y, Song G, et al. Cryopreserved dental pulp tissues of exfoliated deciduous teeth is a feasible stem cell resource for regenerative medicine. PLoS One. 2012;7, e51777.","journal-title":"PLoS One."},{"key":"91_CR18","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1177\/0022034513490732","volume":"92","author":"Y Makino","year":"2013","unstructured":"Makino Y, Yamaza H, Akiyama K, Ma L, Hoshino Y, Nonaka K, et al. Immune therapeutic potential of stem cells from human supernumerary teeth. J Dent Res. 2013;92:609\u201315.","journal-title":"J Dent Res."},{"key":"91_CR19","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1089\/scd.2012.0226","volume":"22","author":"Y Tang","year":"2013","unstructured":"Tang Y, Xie H, Chen J, Geng L, Chen H, Li X, et al. Activated NF-\u03baB in bone marrow mesenchymal stem cells from systemic lupus erythematosus patients inhibits osteogenic differentiation through downregulating Smad signaling. Stem Cells Dev. 2013;22:668\u201378.","journal-title":"Stem Cells Dev."},{"key":"91_CR20","first-page":"19","volume":"25","author":"AJ Friedenstein","year":"1980","unstructured":"Friedenstein AJ. Stromal mechanisms of bone marrow: cloning in vitro and retransplantation in vivo. Haematol Blood Transfus. 1980;25:19\u201329.","journal-title":"Haematol Blood Transfus."},{"key":"91_CR21","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1182\/blood-2008-10-182246","volume":"113","author":"T Yamaza","year":"2009","unstructured":"Yamaza T, Miura Y, Akiyama K, Bi Y, Sonoyama W, Gronthos S, et al. Mesenchymal stem cell-mediated ectopic hematopoiesis alleviates aging-related phenotype in immunocompromised mice. Blood. 2009;113:2595\u2013604.","journal-title":"Blood."},{"key":"91_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le BK, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315\u20137.","journal-title":"Cytotherapy."},{"key":"91_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002615","volume":"3","author":"T Yamaza","year":"2008","unstructured":"Yamaza T, Miura Y, Bi Y, Liu Y, Akiyama K, Sonoyama W, et al. Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents. PLoS One. 2008;3, e2615.","journal-title":"PLoS One."},{"key":"91_CR24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/0022034510387796","volume":"90","author":"T Yamaza","year":"2011","unstructured":"Yamaza T, Ren G, Akiyama K, Chen C, Shi Y, Shi S. Mouse mandible contains distinctive mesenchymal stem cells. J Dent Res. 2011;90:317\u201324.","journal-title":"J Dent Res."},{"key":"91_CR25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJM199502023320506","volume":"332","author":"SC Manolagas","year":"1995","unstructured":"Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med. 1995;332:305\u201311.","journal-title":"N Engl J Med"},{"key":"91_CR26","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/art.30309","volume":"63","author":"K Oshita","year":"2011","unstructured":"Oshita K, Yamaoka K, Udagawa N, Fukuyo S, Sonomoto K, Maeshima K, et al. Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production. Arthritis Rheum. 2011;63:1658\u201367.","journal-title":"Arthritis Rheum."},{"key":"91_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072831","volume":"8","author":"A Varin","year":"2013","unstructured":"Varin A, Pontikoglou C, Labat E, Deschaseaux F, Senseb\u00e9 L. CD200R\/CD200 inhibits osteoclastogenesis: new mechanism of osteoclast control by mesenchymal stem cells in human. PLoS One. 2013;8, e72831.","journal-title":"PLoS One."},{"key":"91_CR28","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","volume":"43","author":"K Kurasawa","year":"2000","unstructured":"Kurasawa K, Hirose K, Sano H, Endo H, Shinkai H, Nawata Y, et al. Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum. 2000;43:2455\u201363.","journal-title":"Arthritis Rheum."},{"key":"91_CR29","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1191\/096120300678828703","volume":"9","author":"CK Wong","year":"2000","unstructured":"Wong CK, Ho CY, Li EK, Lam CW. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus. 2000;9:589\u201393.","journal-title":"Lupus."},{"key":"91_CR30","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jocd.2011.12.002","volume":"15","author":"MI Souto","year":"2012","unstructured":"Souto MI, Coelho A, Guo C, Mendon\u00e7a LM, Pinheiro MF, Papi JA, et al. The prevalence of low bone mineral density in Brazilian patients with systemic lupus erythematosus and its relationship with the disease damage index and other associated factors. J Clin Densitom. 2012;15:320\u20137.","journal-title":"J Clin Densitom."},{"key":"91_CR31","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1007\/s00198-012-2157-9","volume":"24","author":"J Jacobs","year":"2013","unstructured":"Jacobs J, Korswagen LA, Schilder AM, van Tuyl LH, Dijkmans BA, Lems WF, et al. Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus. Osteoporos Int. 2013;24:1827\u201333.","journal-title":"Osteoporos Int."},{"key":"91_CR32","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1359\/jbmr.2000.15.7.1384","volume":"15","author":"A Oleksik","year":"2000","unstructured":"Oleksik A, Lips P, Dawson A, Minshall ME, Shen W, Cooper C, et al. Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res. 2000;15:1384\u201392.","journal-title":"J Bone Miner Res."},{"key":"91_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00223-004-2222-2","volume":"76","author":"R Hasserius","year":"2005","unstructured":"Hasserius R, Karlsson B, Jonsson B, Redlund-Johnell I, Johnell O. Long-term morbidity and mortality after a clinically diagnosed vertebral fracture in the elderly \u2013 a 12 and 22 year follow-up of 257 patients. Calcif Tissue Int. 2005;76:235\u201342.","journal-title":"Calcif Tissue Int."},{"key":"91_CR34","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/s00198-010-1208-3","volume":"21","author":"PD Miller","year":"2010","unstructured":"Miller PD, Derman RJ. What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis? Osteoporos Int. 2010;21:1793\u2013802.","journal-title":"Osteoporos Int."},{"key":"91_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/0961203306075793","volume":"16","author":"LY Sun","year":"2007","unstructured":"Sun LY, Zhang HY, Feng XB, Hou YY, Lu LW, Fan LM. Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus. 2007;16:121\u20138.","journal-title":"Lupus."},{"key":"91_CR36","doi-asserted-by":"publisher","first-page":"826182","DOI":"10.1155\/2012\/826182","volume":"2012","author":"Y Tang","year":"2012","unstructured":"Tang Y, Ma X, Zhang H, Gu Z, Hou Y, Gilkeson GS, et al. Gene expression profile reveals abnormalities of multiple signaling pathways in mesenchymal stem cell derived from patients with systemic lupus erythematosus. Clin Dev Immunol. 2012;2012:826182.","journal-title":"Clin Dev Immunol."},{"key":"91_CR37","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/1074-7613(95)90070-5","volume":"3","author":"Z Yao","year":"1995","unstructured":"Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, Comeau MR, et al. Herpes virus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity. 1995;3:811\u201321.","journal-title":"Immunity."},{"key":"91_CR38","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123\u201332.","journal-title":"Nat Immunol."},{"key":"91_CR39","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ni1261","volume":"6","author":"H Park","year":"2005","unstructured":"Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6:1133\u201341.","journal-title":"Nat Immunol."},{"key":"91_CR40","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.intimp.2010.11.010","volume":"11","author":"K Okamoto","year":"2011","unstructured":"Okamoto K, Takayanagi H. Osteoclasts in arthritis and Th17 cell development. Int Immunopharmacol. 2011;11:543\u20138.","journal-title":"Int Immunopharmacol."},{"key":"91_CR41","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/eci.12158","volume":"43","author":"R Zhao","year":"2013","unstructured":"Zhao R. Immune regulation of bone loss by Th17 cells in oestrogen-deficient osteoporosis. Eur J Clin Invest. 2013;43:1195\u2013202.","journal-title":"Eur J Clin Invest."},{"key":"91_CR42","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1172\/JCI5703","volume":"103","author":"S Kotake","year":"1999","unstructured":"Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest. 1999;103:1345\u201352.","journal-title":"J Clin Invest."},{"key":"91_CR43","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1084\/jem.20061775","volume":"203","author":"K Sato","year":"2006","unstructured":"Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006;203:2673\u201382.","journal-title":"J Exp Med."},{"key":"91_CR44","doi-asserted-by":"publisher","first-page":"9469","DOI":"10.1073\/pnas.1300532110","volume":"110","author":"J Chang","year":"2013","unstructured":"Chang J, Liu F, Lee M, Wu B, Ting K, Zara JN, et al. NF-\u03baB inhibits osteogenic differentiation of mesenchymal stem cells by promoting \u03b2-catenin degradation. Proc Natl Acad Sci U S A. 2013;110:9469\u201374.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"91_CR45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/imm.12142","volume":"141","author":"BW Kirkham","year":"2014","unstructured":"Kirkham BW, Kavanaugh A, Reich K. Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis. Immunology. 2014;141:133\u201342.","journal-title":"Immunology."},{"key":"91_CR46","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","volume":"382","author":"D Baeten","year":"2013","unstructured":"Baeten D, Baraliakos X, Braun J, Sieper J, Emery P, van der Heijde D, et al. Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2013;382:1705\u201313.","journal-title":"Lancet."},{"key":"91_CR47","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.4049\/jimmunol.1003370","volume":"186","author":"B P\u00f6llinger","year":"2011","unstructured":"P\u00f6llinger B, Junt T, Metzler B, Walker UA, Tyndall A, Allard C, et al. Th17 cells, not IL-17+ \u03b3\u03b4 T cells, drive arthritic bone destruction in mice and humans. J Immunol. 2011;186:2602\u201312.","journal-title":"J Immunol."},{"key":"91_CR48","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1002\/jbmr.2228","volume":"29","author":"AM Tyagi","year":"2014","unstructured":"Tyagi AM, Mansoori MN, Srivastava K, Khan MP, Kureel J, Dixit M, et al. Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-\u03b1 antibodies. J Bone Miner Res. 2014;29:1981\u201392.","journal-title":"J Bone Miner Res."},{"key":"91_CR49","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.semarthrit.2013.04.006","volume":"43","author":"WB van den Berg","year":"2013","unstructured":"van den Berg WB, McInnes IB. Th17 cells and IL-17 \u2013 a focus on immunopathogenesis and immunotherapeutics. Semin Arthritis Rheum. 2013;43:158\u201370.","journal-title":"Semin Arthritis Rheum."},{"key":"91_CR50","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/nm.2542","volume":"17","author":"Y Liu","year":"2011","unstructured":"Liu Y, Wang L, Kikuiri T, Akiyama K, Chen CD, Xu XT, et al. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-Gamma and TNF-Alpha. Nat Med. 2011;17:1594\u2013601.","journal-title":"Nat Med."},{"key":"91_CR51","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2011.06.008","volume":"9","author":"AI Caplan","year":"2013","unstructured":"Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell. 2013;9:11\u20135.","journal-title":"Cell Stem Cell."},{"key":"91_CR52","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.stem.2012.03.007","volume":"10","author":"K Akiyama","year":"2012","unstructured":"Akiyama K, Chen C, Wang D, Xu X, Qu C, Yamaza T, et al. Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-FAS-mediated T cell apoptosis. Cell Stem Cell. 2012;10:544\u201355.","journal-title":"Cell Stem Cell."},{"key":"91_CR53","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4049\/jimmunol.0902007","volume":"185","author":"S Ghannam","year":"2010","unstructured":"Ghannam S, P\u00e8ne J, Torcy-Moquet G, Jorgensen C, Yssel H. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. J Immunol. 2010;185:302\u201312.","journal-title":"J Immunol."},{"key":"91_CR54","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.exphem.2012.05.006","volume":"40","author":"X Qu","year":"2012","unstructured":"Qu X, Liu X, Cheng K, Yang R, Zhao RC. Mesenchymal stem cells inhibit Th17 cell differentiation by IL-10 secretion. Exp Hematol. 2012;40:761\u201370.","journal-title":"Exp Hematol."},{"key":"91_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2013.94","volume":"45","author":"MB Murphy","year":"2013","unstructured":"Murphy MB, Moncivais K, Caplan AI. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med. 2013;45, e54.","journal-title":"Exp Mol Med."}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-015-0091-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-015-0091-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-015-0091-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-015-0091-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:27:41Z","timestamp":1728923261000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-015-0091-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,27]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["91"],"URL":"https:\/\/doi.org\/10.1186\/s13287-015-0091-4","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,27]]},"assertion":[{"value":"22 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"104"}}